Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial.
Nikolai Kragøe AndresenAndreas Hagen RøssevoldClaire QuaghebeurBjørnar GiljeBeate BogeAndrea GombosRagnhild Sørum FalkRandi R MathiesenLars JulsrudØystein GarredHege G RussnesRagnhild Reehorst LereimSudhir Kumar ChauhanOle Christian LingjærdeClaire DunnBjørn NaumeJon Amund KytePublished in: Journal for immunotherapy of cancer (2024)
ClinicalTrials.gov Identifier: NCT03409198.